Effects of levosimendan in patients with acute heart failure and cardiorenal syndrome

FUNDING ACKNOWLEDGEMENTS: Type of funding sources: None. INTRODUCTION: Cardiorenal syndrome (CRS) is common in patients with acute heart failure (AHF) and is associated with poor prognosis. Levosimendan (LVS) is an inodilator used in AHF and has beneficial effects on renal function (RF). However, it...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Eur Heart J Acute Cardiovasc Care
Autors principals: Ribeiro Da Silva, M, Santos Silva, G, Caeiro, D, Passos Silva, M, Guerreiro, C, Teixeira, P, Ribeiro Queiros, P, Brandao, M, Ferreira, D, Sousa, O, Dias, A, Rodrigues, A, Braga, P
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2021
Matèries:
16.4.1 - Pharmacotherapy
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8264012/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ehjacc/zuab020.028
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars